---
title: "Ambenonium - Myasthenia Gravis"
sidebar: mydoc_sidebar
permalink: db01122-mesh-d009157-1.html
toc: false 
---


Path ID: `DB01122_MESH_D009157_1`
{% include image.html url="images/db01122-mesh-d009157-1.png" file="db01122-mesh-d009157-1.png" alt="db01122-mesh-d009157-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000549">MESH:D000549 </a> | ambenonium | Drug |
| <a href="https://identifiers.org/UniProt:P22303">UniProt:P22303 </a> | Acetylcholinesterase | Protein |
| <a href="https://identifiers.org/GO:0001507">GO:0001507 </a> | acetylcholine catabolic process in synaptic cleft | BiologicalProcess |
| <a href="https://identifiers.org/HP:0001324">HP:0001324 </a> | Muscle weakness | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D009157">MESH:D009157 </a> | Myasthenia Gravis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ambenonium | DECREASES ACTIVITY OF | Acetylcholinesterase |
| Acetylcholinesterase | POSITIVELY REGULATES | Acetylcholine Catabolic Process In Synaptic Cleft |
| Acetylcholine Catabolic Process In Synaptic Cleft | CONTRIBUTES TO | Muscle Weakness |
| Muscle Weakness | MANIFESTATION OF | Myasthenia Gravis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01122#mechanism-of-action](https://go.drugbank.com/drugs/DB01122#mechanism-of-action)
  - [https://www.uniprot.org/uniprot/P22303#function](https://www.uniprot.org/uniprot/P22303#function)
  - [https://en.wikipedia.org/wiki/Myasthenia_gravis](https://en.wikipedia.org/wiki/Myasthenia_gravis)
